lithium 500mg phexin 250 mg tablet use amoxicillin alternative over the counter protonix vs zantac 150 depo medrol alternative propecia generika rezeptfrei cefadroxil 500 mg cost floxin 200 mg tablet natural alternative to minocycline for acne levothroid 50 clonidine 100 mcg vytorin 10 40 price minipress 10mg clonidine kaufen ohne rezept ampicillin 500mg 4 times a day natures aid celadrin 500mg tadalafil generika 20mg actonel risedronate sodium 150 mg hoodia 2000 tr propranolol 20 mg price flomax 10 pump cefadroxil 500 mg cost clomiphene 100mg side effects silagra 100 nebenwirkungen pulmicort 250 mcg alternative to amlodipine aka norvasc best alternative bystolic penegra 100 nebenwirkungen pravachol 10 promethazine kaufen doxycycline alternatives lyme propecia ersatz desyrel 50 mg zararları benfotiamine 200mg furosemide kaufen alternative drugs to lithium nolvadex 10mg pct less expensive alternative to benicar tamoxifen preis lotensin 20 mg price zanaflex 10 mg wellbutrin 150 sr once a day zenegra-md 100 mg nedir nolvadex 20 mg kaufen prandina guru s3 preis serevent diskus 60 einzeln p preisvergleich herbal alternative to diamox lamisil once kaufen adaalat 7th may 2015 clomiphene citrate 50 mg x50 voltaren preis schweiz jelly viagra kaufen abilify 20 mg price wellbutrin 150 sr once a day vytorin 10 40 price indocin 50 mg gout calcium carbonate 450 mg and vitamin d 200iu isoniazid 150 minocycline 100mg cap phexin 500mg used for what is ciplox 250 mg used for less expensive alternative to benicar singulair ersatz clomid 150mg success flagyl 500 kaufen use of seroflo 250 casodex tab 50mg lotensin 10 mg propecia preisvergleich casodex 150 mg procardia xl alternative colospa 200 natural alternatives to nolvadex protonix 20 mg vs 40 mg minocin 100 mg prezzo prilosec recall 2015 generika blopress ponstel 250 dosage singulair ersatz 8020 reglan cialis wirkung bei frauen risperdal consta generika feldene d 20mg micardis 20 mg price allergic to keflex alternative baclofen 20 mg get you high fucidine 20 mg preis otc clomid alternative natural alternative to cytotec maxalt 10 mg side effects calcium carbonate 450 mg and vitamin d 200iu lisinopril 20 mg h147 cipro 500mg tablets ampicillin-t kaufen xenical preisvergleich angebote proscar 2015 hoodia 2000 tr zyban 150 mg 60 alternative allo zovirax lotensin 10 mg cena duomox 500 cena cefadroxil 500 mg cost how to use fertomid 50 mg synthroid alternatives armour clomid 150mg success alternative zu kamagra cardizem 100mg propecia 1mg preis casodex 150 mg preis was bewirkt cialis bei frauen imitrex 100 mg dosing alternative norvasc citalopram 10mg kaufen fosamax 10 nizoral 50ml Two New Studies: The State of Philanthropy and What's Next - Collins Group
Skagit Valley Hospital

Two New Studies: The State of Philanthropy and What’s Next



Two studies released last month provide an interesting look at the current state of philanthropy. Reviewed together, they cover recent changes within our local funder community, and what we can expect to see in terms of national funding trends in the years ahead.

From Crisis to Opportunity: Learning from One Region’s Response to the Economic Downturn is an FSG Social Impact Advisor report that profiles Northwest funders who changed their policies and practices in response to urgent needs over the past few years. With input and comments from a large number of Pacific Northwest funders, the report explores four guiding principles of Northwest funders for the challenge of “doing more with less.” It also provides the reader with ideas on which of these strategies will continue to drive giving into the future.  While this report has national significance, its focused look into Pacific Northwest funders means that it could not be more relevant to our community.

What’s Next for Philanthropy: Acting Bigger and Adapting Better in a Networked World is a study funded by the W.K. Kellogg Foundation and the Robert Wood Johnson Foundation and national in scope that explores what’s next for philanthropy in the coming decade. Moving beyond the past decade’s focus on efficiency and effectiveness, the study argues that the “next practices” for philanthropy will include an additional focus on how funders can act bigger and adapt better for increased impact.

Pacific Northwest funders’ actions over the past two years indicate that this region will continue to be at the forefront of philanthropic leadership in the next decade. Many of the “next practices” for acting bigger and adapting better are practices being implemented in our region: looking to understand the larger context of problems; activating networks and leveraging resources across sectors; and continuing to take risks. Reading these reports side-by-side reminded me of how committed and determined our funding community is, and of the incredible role they play in addressing urgent needs and affecting longer-term social change.


Like this post? Why not share it?


About the Author

Natalie Lamberjack

Natalie Lamberjack CFRE

Senior Consultant

Natalie dials into the needs of her clients by keeping a calm eye on the big picture view of the nonprofit sector.


Leave a Reply